Filter posts

#BIOCEO18: A Bright Future

“A transformative year in medicine.” That’s how BIO President and CEO Jim Greenwood recently described …

#BIOCEO18: Paradigm Shift Creating New Opportunities in China

The past few years have been a time of tremendous change in the world’s second …

#BIOCEO18: “A Moment Decades in the Making”

It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking …

Here We Go Again (But In a Good Way)

“We achieved the lowest drug trend since we began measuring drug trend data in 1993.” …

High Caliber Investors Flock to BIO CEO & Investor Conference

Today the 20th BIO CEO & Investor Conference opens in New York City amid a …

2018 World Congress Returns to Philadelphia

This summer, BIO’s World Congress on Industrial Biotechnology returns to Philadelphia for the first time …

New Report Series Launched on The State of Innovation in Highly Prevalent Chronic Diseases

BIO’s Industry Analysis team has released its first report in a new series on the …

#MakeHistory: Highlighting History | Japan’s Accelerated Innovations

Ask anyone in the life sciences field to list today’s global titans of industry and …

BIO CEO and Investor Conference at the Center of Biotech Innovation

The 20th annual BIO CEO & Investor Conference will be held on February 12-13, 2018 …

BIO CEO: The Perfect Place to Continue The Momentum From A Strong 2017 Biotech Market

The 20th Annual BIO CEO & Investor Conference, taking place February 12-13 in New York …